Table 2 Association of pulmonary and extra pulmonary sites against major strain lineages
Lineages | Total (N/%) | N (%) | N (%) | OR (95% CI)/P value |
|---|---|---|---|---|
N = 2092 | PTB1 (N = 1089) | EPTB2 (N = 1003) | ||
M. bovis | 151 (7.3) | 32 (2.9) | 119 (11.8) | 0.22 (0.15–0.33)/ < 0.0001 |
Delhi/CAS | 562 (26.9) | 287 (26.3) | 275 (27.4) | 0.94 (0.78–1.15)/ 0.58 |
EAI | 296 (14.2) | 138 (12.7) | 158 (15.7) | 0.77 (0.60–0.99)/ 0.04 |
Beijing | 114 (5.4) | 71 (6.5) | 43 (4.3) | 1.55 (1.05–2.29)/ 0.02 |
Haarlem | 202 (9.6) | 127 (11.7) | 75 (7.5) | 1.63 (1.21–2.20)/ 0.001 |
LAM | 134 (6.4) | 68 (6.2) | 66 (6.6) | 0.94 (0.66–1.34)/ 0.75 |
Cameroon | 78 (3.7) | 29 (2.7) | 49 (4.9) | 0.53 (0.33–0.85)/ 0.008 |
Ghana | 207 (9.9) | 139 (12.8) | 68 (6.8) | 2.01 (1.48–2.71)/ < 0.0001 |
Uganda I | 58 (2.8) | 17 (1.6) | 41 (4.1) | 0.37 (0.21–0.66)/ 0.0007 |
URAL | 40 (1.9) | 16 (1.5) | 24 (2.4) | 0.60 (0.32–1.1)/ 0.127 |
TUR | 31 (1.5) | 17 (1.6) | 14 (1.4) | 1.12 (0.55–2.28)/ 0.75 |
S | 45 (2.1) | 31 (2.8) | 14 (1.4) | 2.07 (1.09–3.91)/ 0.025 |
Uganda II | 16 (0.76) | 2 (0.2) | 14 (1.4) | 0.13 (0.03–0.57)/ 0.007 |
New-I | 30 (1.4) | 15 (1.4) | 15 (1.5) | 0.92 (0.44–1.89)/ 0.82 |
Others 3 | 144 (6.9) | 100 (9.2) | 28 (2.8) | – |